Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i> -Mutant Metastatic Breast Cancer
2019 · Cancer Discovery · 108 citations
https://doi.org/10.1158/2159-8290.cd-19-0966
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
1.6K
Citations
16
h-index
18
i10-index
Alexander N. Gorelick is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Advanced Breast Cancer Therapies & Nuclear Structure and Function. The author has an h-index of 16, co-authored 74 publications.
ORCID: 0000-0001-6736-8246https://doi.org/10.1158/2159-8290.cd-19-0966
https://doi.org/10.1038/s41588-024-01724-8
https://doi.org/10.1038/s41588-025-02078-5
Click to start Chat